Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis

Christina Caruso; Wilbur A. Lam

doi:10.1055/s-0041-1723798

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2021; 47(02): 120-128
DOI: 10.1055/s-0041-1723798

Review Article

Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis

Christina Caruso

¹Department of Pediatrics, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia

,

Wilbur A. Lam

¹Department of Pediatrics, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia

²Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine, Georgia Institute of Technology, Atlanta, Georgia

› Institutsangaben

Abstract

Hemostasis is a complex wound-healing process involving numerous mechanical and biochemical mechanisms and influenced by many factors including platelets, coagulation factors, and endothelial components. Slight alterations in these mechanisms can lead to either prothrombotic or bleeding consequences, and such hemostatic imbalances can lead to significant clinical consequences with resultant morbidity and mortality. An ideal hemostasis assay would not only address all the unique processes involved in clot formation and resolution but also take place under flow conditions to account for endothelial involvement. Global assays do exist; however, these assays are not flow based. Flow-based assays have been limited secondary to their large blood volume requirements and low throughput, limiting potential clinical applications. Microfluidic-based assays address the aforementioned limitations of both global and flow-based assays by utilizing standardized devices that require low blood volumes, offer reproducible analysis, and have functionality under a range of shear stresses and flow conditions. While still largely confined to the preclinical space, here we aim to discuss these novel technologies and potential clinical implications, particularly in comparison to the current, commercially available point-of-care assays.

Keywords

hemostasis - platelet function - coagulation assays - point-of-care testing - microfluidics

Volltext

Referenzen

References
1 Wolberg AS, Aleman MM, Leiderman K, Machlus KR. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg 2012; 114 (02) 275-285
2 Tynngård N, Lindahl TL, Ramström S. Assays of different aspects of haemostasis - What do they measure?. Thromb J 2015; 13 (08) 8
3 Branchford BR, Ng CJ, Neeves KB, Di Paola J. Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis. Thromb Res 2015; 136 (01) 13-19
4 Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78 (06) 1456-1461
5 Neeves KB, Illing DAR, Diamond SL. Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys J 2010; 98 (07) 1344-1352
6 Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 1973; 5 (02) 167-179
7 Hochmuth RM, Mohandas N, Blackshear Jr PL. Measurement of the elastic modulus for red cell membrane using a fluid mechanical technique. Biophys J 1973; 13 (08) 747-762
8 Mooney M, Ewart RH. The conicylindrical viscometer. Physics 1934; 5: 350
9 Weiss HJ, Turitto VT, Vicic WJ, Baumgartner HR. Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency. Blood 1984; 63 (05) 1004-1014
10 Escolar G, Galán AM, Mazzara R, Castillo R, Ordinas A. Measurement of platelet interactions with subendothelial substrata: relevance to transfusion medicine. Transfus Med Rev 2001; 15 (02) 144-156
11 Weiss HJ, Tschopp TB, Baumgartner HR. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease. N Engl J Med 1975; 293 (13) 619-623
12 Multiplate ® Analyzer. Roche website. Updated May 2020. Accessed May 10, 2020 at: https://diagnostics.roche.com/global/en/products/instruments/multiplate-6-analyzer.html
13 Sibbing D, Aradi D, Jacobshagen C. et al; TROPICAL-ACS Investigators. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial. Lancet 2017; 390 (10104): 1747-1757
14 Plateletworks ® POC Platelet Function Test. Helena Laboratories website. Updated 2020. Accessed May 10, 2020 at: https://www.helena.com/plateletworks.html
15 PFA-100 System. Siemens Healthineers USA website. Updated 2020. Accessed May 11, 2020 at: https://www.siemens-healthineers.com/en-us/hemostasis/systems/pfa-100
16 Koscielny J, Ziemer S, Radtke H. et al. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10 (03) 195-204
17 Koscielny J, von Tempelhoff GF, Ziemer S. et al. A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10 (02) 155-166
18 Shaydakov ME, Sigmon DF, Blebea J. Thromboelastography (TEG). StatPearls Publishing. 2020 . Accessed May 15, 2020 at: https://www.ncbi.nlm.nih.gov/books/NBK537061/
19 Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88 (02) 312-319
20 Agarwal S, Johnson RI, Shaw M. Preoperative point-of-care platelet function testing in cardiac surgery. J Cardiothorac Vasc Anesth 2015; 29 (02) 333-341
21 TEG System. Haemonetics website. Updated 2020. Accessed May 15, 2020 at: http://teg.haemonetics.com/en
22 Kim BJ, Lee SY, Jee S, Atajanov A, Yang S. Micro-viscometer for measuring shear-varying blood viscosity over a wide-ranging shear rate. Sensors (Basel) 2017; 17 (06) 1442
23 Sonoclot ® Coagulation & Platelet Function Analyzer. Sienco website. Updated 2018. Accessed May 1, 2020 at: https://www.sienco.com/sonoclot-world/training-and-support/principle-of-operation-2018.pdf
24 Bischof DB, Ganter MT, Shore-Lesserson L. et al. Viscoelastic blood coagulation measurement with Sonoclot predicts postoperative bleeding in cardiac surgery after heparin reversal. J Cardiothorac Vasc Anesth 2015; 29 (03) 715-722
25 Matsumoto T, Nogami K, Shima M. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis. Thromb Haemost 2013; 110 (04) 761-768
26 Koltsova EM, Balandina AN, Grischuk KI. et al. The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery. J Perinat Med 2018; 46 (03) 251-260
27 Okorie UM, Diamond SL. Matrix protein microarrays for spatially and compositionally controlled microspot thrombosis under laminar flow. Biophys J 2006; 91 (09) 3474-3481
28 Gutierrez E, Petrich BG, Shattil SJ, Ginsberg MH, Groisman A, Kasirer-Friede A. Microfluidic devices for studies of shear-dependent platelet adhesion. Lab Chip 2008; 8 (09) 1486-1495
29 Neeves KB, Maloney SF, Fong KP. et al. Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear-resistance of platelet aggregates. J Thromb Haemost 2008; 6 (12) 2193-2201
30 Neeves KB, Onasoga AA, Wufsus AR. The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury. Curr Opin Hematol 2013; 20 (05) 417-423
31 Hansen RR, Wufsus AR, Barton ST, Onasoga AA, Johnson-Paben RM, Neeves KB. High content evaluation of shear dependent platelet function in a microfluidic flow assay. Ann Biomed Eng 2013; 41 (02) 250-262
32 Tsai M, Kita A, Leach J. et al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest 2012; 122 (01) 408-418
33 Westein E, van der Meer AD, Kuijpers MJ, Frimat JP, van den Berg A, Heemskerk JW. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proc Natl Acad Sci U S A 2013; 110 (04) 1357-1362
34 Neeves KB, Onasoga AA, Hansen RR. et al. Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays. PLoS One 2013; 8 (01) e54680
35 Karimi S, Farré-Lladós J, Mir E, Escolar G, Casals-Terré J. Hemostasis-on-a-chip: impedance spectroscopy meets microfluidics for hemostasis evaluation. Micromachines (Basel) 2019; 10 (08) 534
36 Hosokawa K, Ohnishi T, Kondo T. et al. A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. J Thromb Haemost 2011; 9 (10) 2029-2037
37 Li R, Fries S, Li X, Grosser T, Diamond SL. Microfluidic assay of platelet deposition on collagen by perfusion of whole blood from healthy individuals taking aspirin. Clin Chem 2013; 59 (08) 1195-1204
38 Li M, Hotaling NA, Ku DN, Forest CR. Microfluidic thrombosis under multiple shear rates and antiplatelet therapy doses. PLoS One 2014; 9 (01) e82493
39 Harris LF, Rainey P, Castro-López V, O'Donnell JS, Killard AJ. A microfluidic anti-Factor Xa assay device for point of care monitoring of anticoagulation therapy. Analyst (Lond) 2013; 138 (17) 4769-4776
40 Kim DY, Steckl AJ. Electrowetting on paper for electronic paper display. ACS Appl Mater Interfaces 2010; 2 (11) 3318-3323
41 Ogawa S, Szlam F, Dunn AL. et al. Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood. Haemophilia 2012; 18 (06) 926-932
42 Colace TV, Fogarty PF, Panckeri KA, Li R, Diamond SL. Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels. J Thromb Haemost 2014; 12 (02) 147-158
43 Sakurai Y, Hardy ET, Ahn B. et al. A microengineered vascularized bleeding model that integrates the principal components of hemostasis. Nat Commun 2018; 9 (01) 509
44 Sugimoto M, Matsui H, Mizuno T. et al. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood 2003; 101 (03) 915-920
45 Li R, Elmongy H, Sims C, Diamond SL. Ex vivo recapitulation of trauma-induced coagulopathy and preliminary assessment of trauma patient platelet function under flow using microfluidic technology. J Trauma Acute Care Surg 2016; 80 (03) 440-449
46 de Witt SM, Swieringa F, Cavill R. et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun 2014; 5: 4257
47 Kosaka PM, Pini V, Ruz JJ. et al. Detection of cancer biomarkers in serum using a hybrid mechanical and optoplasmonic nanosensor. Nat Nanotechnol 2014; 9 (12) 1047-1053
48 Thrombodynamics Analyser T2-T. Hemacore website. . Updated 2020. Accessed May 25, 2020 at: https://thrombodynamics.com/products/analyser-t2-t